Akebia Therapeutics Inc. Common Stock (AKBA)
About The Company
Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is Vadadustat, an oral therapy, which is used for the treatment of anemia related to chronic kidney disease in non-dialysis and dialysis patients. The company is also developing a HIF-based portfolio of product for the treatment of anemia. Geographically, all the business activity is functioned through the region of United States.
| IPO Year | Sector | Industry |
|---|---|---|
| 2014 | Health Care | Biotechnology: Pharmaceutical Preparations |
Akebia Therapeutics Inc. (AKBA) Latest News
Company Contact & Address (AKBA)
| Corporate Headquarters | Phone | Website |
|---|---|---|
| 245 FIRST STREET SUITE 1100, CAMBRIDGE, Massachusetts, 2142, United States |
+1 617 871-2098 | Official AKBA Website |
AKBA Key Executives
Ownership and management information.
Key Data Points*
| Exchange | Not Available | Market Cap | Not Available |
|---|---|---|---|
| Sector | Health Care | P/E Ratio | Not Available |
| Industry | Biotechnology: Pharmaceutical Preparations | Forward P/E 1 Yr. | Not Available |
| 1 Year Target | Not Available | Earnings Per Share (EPS) | Not Available |
| Today’s High/Low | Not Available | Annualized Dividend | Not Available |
| Share Volume | Not Available | Ex Dividend Date | Not Available |
| Average Volume | Not Available | Dividend Pay Date | Not Available |
| Previous Close | Not Available | Current Yield | Not Available |
| 52 Week High/Low | Not Available | Beta | Not Available |
* Information and data may delayed
Officers & Directors @ AKBA
Jobs & Employment at Akebia Therapeutics Inc.
| LinkedIn Company Page | https://www.linkedin.com/company/akebia-therapeutics |
|---|---|
| Official Career & Employment Page | View LinkedIn page for more jobs & careers info. |
Related & Similar Stock Symbols
 CRDLCardiol Therapeutics Inc. Class A Common Shares
|
 BRPMUB. Riley Principal 150 Merger Corp. Unit
|
 AZOAutoZone Inc. Common Stock
|
Friday, August 12, 2022, 5:32 am (EST)
